Detalhe da pesquisa
1.
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.
Hematol Oncol
; 31(2): 72-8, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23027689
2.
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.
Blood
; 110(7): 2316-23, 2007 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17581918